Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens

Japanese Journal of Clinical Oncology

Volumn 39, Issue 9, 2009, Pages 588-594

  Ito, Keiichi ^a   Yoshii, Hidehiko ^a   Asakuma, Junichi ^a   Sato, Akinori ^a   Horiguchi, Akio ^a   Sumitomo, Makoto ^a   Hayakawa, Masamichi ^a   Asano, Tomohiko ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

C reactive protein; Nucleolar grade; Prognostic factor; Recurrence; Renal cell carcinoma

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENCE RISK; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VOLUME; VASCULAR TUMOR;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARCINOMA, RENAL CELL; CELL NUCLEOLUS; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 69949116350     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp068     Document Type: Article

References (15)

1. Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A. Prognostic indicators for renal cell carcinoma: A multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000;163:1090-5.
2. Ficarra V, Righetti R, Martignoni G, D'Amico A, Pilloni S, Rubilotta E, et al. Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int 2001;67:130-4.
3. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score. J Urol 2002;168:2395-400.
4. Ito K, Asano T, Yoshii H, Satoh A, Sumitomo M, Hayakawa M. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma. Int J Urol 2006;13:1365-70.
5. Japanese Urological Association. Pathological grading; in general rule for clinical and pathological studies on renal cell carcinoma. In: The Japanese Society of Pathology and Japan Radiological Society, 3rd edn. Tokyo: Kanehara 1999; 73.
6. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, et al. TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:992-3.
7. Novara G, Martignoni G, Artibani W, Ficarra V. Grading systems in renal cell carcinoma. J Urol 2007;177:430-6.
8. Medeiros LJ, Jones EC, Aizawa S, Aldape HC, Cheville JC, Goldstein NS, et al. Grading of renal cell carcinoma: Workgroup No. 2. Union Internationale Contre le Cancer and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:990-1.
9. Hand JR, Broders AC. Carcinoma of the kidney: The degree of malignancy in relation to factors bearing on prognosis. J Urol 1932;28:199.
10. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63.
11. Goldstein NS. Grading of renal cell carcinoma. Urol Clin North Am 1999;26:637-42.
12. Al-Aynati M, Chen V, Salama S, Shuhaibar H, Treleaven D, Vincic L. Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch Pathol Lab Med 2003; 127:593-6.
13. Ramsey S, Lamb GW, Aitchison M, McMillan DC. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer. BJU Int 2008;101:959-63.
14. Karakiewicz PI, Hutterer GC, Trinh QD, Jeldres C, Perrotte P, Gallina A, et al. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: A European study of 313 patients. Cancer 2007;110:1241-7.
15. Saito K, Tatokoro M, Fujii Y, Iimura Y, Koga F, Kawakami S, et al. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma. Eur Urol 2009;55:1145-54.